Israeli biotech company to build $10 million R&D facility in St. Louis

Evogene Ltd., a biotech company that has partnered with Monsanto for nearly a decade, has plans in place to build a 6,000-square-foot research and development facility at Bio-Research & Development Growth (BRDG) Park.

The project is estimated to cost $10 million and will broaden the company’s existing predictive discovery and validation capabilities. The facility will serve Evogene’s growing insect control activities and is projected to be fully operational by the end of 2015.

[St. Louis Business Journal]